During the 2 day event we were joined in Budapest by 180 delegates from 35 different countries in EEMEA.
Under the guidance of Prof. Yehuda Shoenfeld, the event started with a focus on COVID-19 and autoimmunity, going from the molecular mechanisms of autoinflammation in COVID patients to molecular mimicry. Later, we had a more canonical session on SLE, updating the audience about the new classification criteria and the p-value of autoantibodies in the identification of Lupus patients. This session was closed with the impact of antibodies profiles on UCTD and with the promising data coming from the new Particle Based Multi Analyte technology (PMAT) regarding patients with Connective Tissue Disease (CTD)
Afternoon session focus was on the updates related to antiphospholipid syndrome (APS), underlining the value of anti-PS/PT and anti-Domain I on both Obstetric and Vascular APS and we finished the first day with a focus on Rheumatoid Arthritis (RA) from the need of standardization of the criteria biomarkers to the need on novel autoantibody to better stratify RA patients.
On the 21st we started with an overview of the most promising biomarkers in the field of autoimmunology, moving then to the importance of an early diagnose in patients with Interstitial Lung Disease and the unmet needs of respirologists regarding diagnose. We closed the first session underlining the concept of likelihood ratios in the assessment of the right diagnosis.
Next focus session was on Inflammatory Myopathies and the clear message was related to the unreliability of current methodologies for detections of patients with such condition, with a hope that the new PMAT technology will resolve these concerns.
The last session of the seminar was fully dedicated to gastrointestinal autoimmunity, new insights on celiac disease, Primary Biliary Cholangitis and Primary Sclerosis Cholangitis.
The 2022 edition of the Scientific Seminars was an enormous success. The Journal Autoimmunity Review, the most important Journal in the field of Autoimmunity, asked Prof. Sciascia and me to write a special issue paper with the highlights from the seminar. The article will be available starting from February 2023.
It is the first time that such a Journal will publish an article dedicate to an autoimmunity event organized by a private IVD company.
Daniele Ielo (Autoimmunity Scientific Manager)



